Back to Search Start Over

The role of Pin1 in the development and treatment of cancer.

Authors :
Min SH
Zhou XZ
Lu KP
Source :
Archives of pharmacal research [Arch Pharm Res] 2016 Dec; Vol. 39 (12), pp. 1609-1620. Date of Electronic Publication: 2016 Aug 29.
Publication Year :
2016

Abstract

Protein phosphorylation and post-phosphorylation events regulate many cellular signaling pathways. Peptidyl-prolyl isomerase (Pin1) is the only peptidyl-prolyl cis/trans isomerase that interacts with numerous oncogenic or tumor suppressive phosphorylated proteins, causes conformational changes in target proteins, and eventually regulates the activities of such proteins. These alterations in activity play a pivotal role in tumorigenesis. Since Pin1 is overexpressed and/or activated in various types of cancers, and the dysregulation of proline-directed phosphorylation contributes to tumorigenesis, Pin1 represents an attractive target for cancer therapy. This review will describe the role of Pin1 in cancer and the current status of Pin1 inhibitor development.

Details

Language :
English
ISSN :
1976-3786
Volume :
39
Issue :
12
Database :
MEDLINE
Journal :
Archives of pharmacal research
Publication Type :
Academic Journal
Accession number :
27572155
Full Text :
https://doi.org/10.1007/s12272-016-0821-x